Updated: May 15, 2020
Historically, since its conception in 2006, the CBC program has been managed by the CBC Leadership composed of the Executive Director and three Scientific Directors, one from each participating university. Each Scientific Director was appointed by the Provost of his or her institution and required an approval of the other two Provosts. The Scientific Directors worked closely together with the Executive Director to provide overall direction and guidance for the CBC.
Day-to-day management of CBC programs rests with an Executive Director, who reports to the CBC Leadership and Provosts. A core Program Management Staff, whose members are distributed among the different CBC campuses, assist with ongoing operations.
The Executive Oversight Board (EOB) provides general oversight of the CBC, holding the CBC accountable for achieving the goals established for Phase 2. The members of the EOB also provide guidance and, where possible, assistance on the major Phase 2 initiatives to expand linkages with the biomedical industry, fundraise, and elevate the public profile of the CBC. Until recently, the Provosts of each of the CBC universities (Northwestern University (NU), the University of Chicago (UChicago), and the University of Illinois at Chicago (UIC)) directly oversaw the CBC and provided institutional responsibility working primarily through the EOB. As of April 20, 2020, following the CBC Governance Committee recommendation, the governance structure of the CBC reports to the CBC universities Chief Scientific Officers (CSOs) who hold the positions of Senior Research Officers at the three CBC universities.
Composed of distinguished biomedical scientists from outside of Chicago, the Scientific Advisory Board (SAB) is currently recruiting new members. SAB’s overarching goal will be to evaluate annually the scientific agenda and programs of the CBC to ensure the highest scientific standards and the stature of the CBC as an intellectual leader in scientific circles are maintained.
CBC Programs’ Review Boards
CBC Accelerator Award program proposals are evaluated by the Accelerator Review Board (ARB), composed of representatives from the pharmaceutical industry, the universities’ technology transfer officers, and mentors identified from the CBC and its member institutions. The Board reviews the projects and makes funding recommendation to the CBC Leadership based on significance, translational potential, marketability of the proposed product, preliminary data, and the soundness of the proposed milestones to discharge key elements of risk.
CBC Catalyst awards are made on the basis of scientific merit and are evaluated by the Catalyst Review Board (CRB) composed of equal numbers of scientists from consortium institutions who serve on a volunteer basis. The Board advises the Scientific Directors and works closely with the Executive Director to define and implement the specifics of the Catalyst Award program.
CBC Organizational Chart
Updated: May 15, 2020